$INJ: Bullish reversal detected on the $INJ daily timeframe.

I’ve been tracking
Looking at the charts,
With the weekly timeframe still showing bullish momentum,
DYOR!
Pesanan dibatalkan
When will this daily correction finally bottom out? It feels like it’s taking forever! TradingView is forcing me to close this idea, but I’m still monitoring the price action and will provide updates as needed. I still believe the daily crossover will happen—it’s just progressing very slowly due to the low market activity during the holidays.
Nota
Injective's price action is very disappointing. It falls like a knife and pumps like a hammer.
When
What does that tell us? This coin is not healthy.
Injective has plenty of projects: AI agents, Helix (a fully featured DEX with lots of pairs), and AUSDT, a stablecoin. But all of this requires a significant amount of cash to operate. And where does that cash come from? Selling $INJ.
Upon further investigation, it appears the tokenomics are misleading.
The reality:
- **54% of all
- There’s a **14.5% yearly inflation** due to POS minting, meaning a lot of
My understanding is that
With no signs from management indicating any changes, I’m putting this coin in the “dying coins” category alongside Celestia and Ordi.
I’ll stop holding it and probably stop analyzing it too. A miracle could happen, of course—but without me.
Nota
Last post about - the coin is milked by the team, so there is no hope for a pump
- most coins launched on INJ got rugged.
- 100k INJ are sold avery hours, someone is dumping.
- 14.5 APR is too high, the PoS system is generating too much inflation.
- the tools like tokenstation are buggy and not one cares about.
This coin is dying, and will exit the top 100 like ORDI and others milked coin that are not delivering their premise.
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.